failure to respond or late response
on 24 Sep 2019
Last Applicant/ Owned by
Sampyeong-dong 696, Bundang-gu, Seongnam
Gyeonggi-do 463-400
KR
Serial Number
88191008 filed on 12th Nov 2018
Registration Number
N/A
Correspondent Address
MARGARET C. MCHUGH
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Custom manufacture of proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; Custom manufacture of in vitro diagnostic devices and antibody detection kits Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and Read More
Proteins in raw material form for scientific and medical research; Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for use by others in manufacturing pharmaceutical and veterinary preparations; proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for scientific and research purposes; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA in disease diagnosis screening, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones for veterinary or medical purposes: hormones; diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
Online retail store services featuring proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; online retail store services featuring vitro diagnostic devices and antibody detection kits
Custom manufacture of proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; Custom manufacture of in vitro diagnostic devices and antibody detection kits
medical research services; scientific research, namely, conducting clinical research trials; research and development of medicines based on protein and peptide therapeutic applications; medical diagnostic services; biological DNA cloning services; protein expression services in the field of biotechnology, namely, DNA gene cloning services, purification process development; laboratory services relating to the production of monoclonal antibodies; medical and scientific research services, namely, monoclonal antibody development, generation and screening and design related thereto
No 88191008
No Service Mark
No 1114570
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
24th Sep 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
24th Sep 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
26th Feb 2019 | NON-FINAL ACTION E-MAILED |
26th Feb 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
26th Feb 2019 | NON-FINAL ACTION WRITTEN |
14th Feb 2019 | ASSIGNED TO EXAMINER |
30th Nov 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
15th Nov 2018 | NEW APPLICATION ENTERED IN TRAM |